Seattle vaccine startup Curevo, which is developing a vaccine against shingles, raised $26 million. The funding comes on the heels of $60 million raised in February to advance the company’s… Read More
Curevo has raised $60 million to develop a new vaccine for shingles, an often-painful condition caused by reactivation of the chickenpox virus. The new funding will enable the Seattle-based startup… Read More